Literature DB >> 29805604

Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma.

Zhongwei Jia1,2, Fangning Wan1,2, Yao Zhu1,2, Guohai Shi1,2, Hailiang Zhang1,2, Bo Dai1,2, Dingwei Ye1,2.   

Abstract

Previous studies have demonstrated that several members of the Forkhead-box (FOX) family of genes are associated with tumor progression and metastasis. The objective of the current study was to screen candidate FOX family genes identified from analysis of molecular networks in clear cell renal cell carcinoma (ccRCC). The expression of FOX family genes as well as FOX family-associated genes was examined, and Kaplan-Meier survival analysis was performed in The Cancer Genome Atlas (TCGA) cohort (n=525). Patient characteristics, including sex, age, tumor diameter, laterality, tumor-node-metastasis, tumor grade, stage, white blood cell count, platelet count, the levels of hemoglobin, overall survival (OS) and disease-free survival (DFS), were collected for univariate and multivariate Cox proportional hazards ratio analyses. A total of seven candidate FOX family genes were selected from the TCGA database subsequent to univariate and multivariate Cox proportional hazards ratio analyses. FOXA1, FOXA2, FOXD1, FOXD4L2, FOXK2 and FOXL1 were associated with poor OS time, while FOXA1, FOXA2, FOXD1 and FOXK2 were associated with poor DFS time (P<0.05). FOXN2 was associated with favorable outcomes for overall and disease-free survival (P<0.05). In the gene cluster network analysis, the expression of FOX family-associated genes, including nuclear receptor coactivator (NCOA)1, NADH-ubiquinone oxidoreductase flavoprotein 3 (NDUFV3), phosphatidylserine decarboxylase (PISD) and pyruvate kinase liver and red blood cell (PKLR), were independent prognostic factors for OS in patients with ccRCC. Results of the present study revealed that the expression of FOX family genes, including FOXA1, FOXA2, FOXD1, FOXD4L2, FOXK2 and FOXL1, and FOX family-associated genes, including NCOA1, NDUFV3, PISD and PKLR, are independent prognostic factors for patients with ccRCC.

Entities:  

Keywords:  Forkhead-box family gene; clear cell renal cell carcinoma; prognosis

Year:  2018        PMID: 29805604      PMCID: PMC5950509          DOI: 10.3892/ol.2018.8405

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  31 in total

1.  A novel homozygous mutation of PKLR gene in a pyruvate-kinase-deficient Korean family.

Authors:  Jeong Ok Park-Hah; Hitoshi Kanno; Won Duck Kim; Hisaichi Fujii
Journal:  Acta Haematol       Date:  2005       Impact factor: 2.195

2.  NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis.

Authors:  Li Qin; Ye-Lin Wu; Michael J Toneff; Dabing Li; Lan Liao; Xiuhua Gao; Fiona T Bane; Jean C-Y Tien; Yixiang Xu; Zhen Feng; Zhihui Yang; Yan Xu; Sarah M Theissen; Yi Li; Leonie Young; Jianming Xu
Journal:  Cancer Res       Date:  2014-04-25       Impact factor: 12.701

3.  Transcriptomic profiling of Forkhead box transcription factors in adult glioblastoma multiforme.

Authors:  Emily Robertson; Christina Perry; Rachel Doherty; Srinivasan Madhusudan
Journal:  Cancer Genomics Proteomics       Date:  2015 May-Jun       Impact factor: 4.069

4.  FOXA1 positively regulates gene expression by changing gene methylation status in human breast cancer MCF-7 cells.

Authors:  Lu Zheng; Bo Qian; Duo Tian; Tong Tang; Shengyun Wan; Lei Wang; Lixin Zhu; Xiaoping Geng
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  Commentary on: "An integrated metabolic atlas of clear cell renal cell carcinoma." Hakimi AA, Reznik E, Lee CH, Creighton CJ, Brannon AR, Luna A, Aksoy BA, Liu EM, Shen R, Lee W, Chen Y, Stirdivant SM, Russo P, Chen YB, Tickoo SK, Reuter VE, Cheng EH, Sander C, Hsieh JJ.: Cancer Cell. 2016 Jan 11;29(1):104-16.

Authors:  Byron H Lee
Journal:  Urol Oncol       Date:  2017-08-05       Impact factor: 3.498

6.  The DNA damage repair protein Ku70 interacts with FOXO4 to coordinate a conserved cellular stress response.

Authors:  Arjan B Brenkman; Niels J F van den Broek; Peter L J de Keizer; Dik C van Gent; Boudewijn M T Burgering
Journal:  FASEB J       Date:  2010-06-22       Impact factor: 5.191

7.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

8.  FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.

Authors:  Wenhuan Guo; Anne L Keener; Yifeng Jing; Liquan Cai; Junkui Ai; Jian Zhang; A L Fisher; Guohui Fu; Zhou Wang
Journal:  Prostate       Date:  2015-03-23       Impact factor: 4.104

9.  Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer.

Authors:  Yeqing Angela Yang; Jindan Yu
Journal:  Genes Dis       Date:  2015-06

10.  MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1.

Authors:  Changwei Dou; Yufeng Wang; Chao Li; Zhikui Liu; Yuli Jia; Qing Li; Wei Yang; Yingmin Yao; Qingguang Liu; Kangsheng Tu
Journal:  Oncotarget       Date:  2015-05-30
View more
  6 in total

1.  Long non-coding RNA tumor protein 53 target gene 1 promotes cervical cancer development via regulating microRNA-33a-5p to target forkhead box K2.

Authors:  Dan Liao; Xiaomei Liu; Xiuying Yuan; Poling Feng; Zhiwei Ouyang; Yanyan Liu; Cuifen Li
Journal:  Cell Cycle       Date:  2022-01-28       Impact factor: 4.534

2.  A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients.

Authors:  Patrick Terrematte; Dhiego Souto Andrade; Josivan Justino; Beatriz Stransky; Daniel Sabino A de Araújo; Adrião D Dória Neto
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

3.  MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1.

Authors:  Xin-Long Ma; Feng Shang; Wei Ni; Jin Zhu; Bin Luo; Yu-Qi Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2018-09-17       Impact factor: 4.553

4.  A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma.

Authors:  Jingmin Zhou; Guanghua Liu; Xingcheng Wu; Zhien Zhou; Jialin Li; Zhigang Ji
Journal:  Dis Markers       Date:  2021-01-14       Impact factor: 3.434

5.  FOXD1 Regulates the Sensitivity of Cetuximab by Regulating the Expression of EGFR in Head and Neck Squamous Cell Cancer.

Authors:  Lan Mu; Jian Zhang; Zhuo Wu; Jingxi Huang; Ying Cui
Journal:  J Healthc Eng       Date:  2022-01-25       Impact factor: 2.682

Review 6.  Regulation and roles of FOXK2 in cancer.

Authors:  Yuanyuan Kang; Kexin Zhang; Lixue Sun; Ying Zhang
Journal:  Front Oncol       Date:  2022-09-12       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.